Company intelligence / Profile preview

PerImmune

Rockville, Maryland, United States
Ownership
Private
Development stage
Other
01

Overview

PerImmune was a private U.S. biopharmaceutical company based in Rockville, Maryland that focused on immunotherapy, cancer vaccines, human monoclonal antibodies, and diagnostic products. Historical reports indicate the company developed products for cancer and infectious disease applications, including a KLH-based bladder cancer immunotherapy program and a physician office-based bladder cancer recurrence test. PerImmune originated from Organon Teknika through a 1996 management buyout and later merged with Intracel in 1998. The company appears to be inactive today as an independent operating business, but it left behind patents and product-development work in oncology immunotherapy and diagnostics.

Therapeutic areas
Infectious DiseasesOncology
Modalities
Monoclonal antibodyVaccineBiologicProtein
Industry
Biotech
02

Drug pipeline

1 asset

OXY-KLH

Preclinical
03

Partnerships

Organon TeknikaProgenics PharmaceuticalsCalifornia medical/surgical instruments company for AuraTek distribution

Beyond the preview

Go deeper on PerImmune.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PerImmune.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call